Cargando…
1813. A Retrospective Review of the Safety and Efficacy of Dalbavancin at Ireland's Largest Acute Medical Hospital
BACKGROUND: Dalbavancin is second-generation lipoglycopeptide antibiotic. It is licensed in Ireland and the United States for the management of acute skin and soft tissue infections. International colleagues report treatment success in its use for patients who are unable to stay in the hospital for...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679163/ http://dx.doi.org/10.1093/ofid/ofad500.1642 |